Prof Pradip Sinha, Co-Founder of InvivoD Solutions and Professor at IIT Kanpur will speak at the 15th Biopharma India conference in Mumbai on 19-20 September 2017.

From Idea to Commercialisation: 10 minutes with Pradip Sinha

Emily Event News Leave a Comment

University is a great source of innovation with huge potential to commercialise ideas to feasible products. To bring you true innovators at the 15th BioPharma India conference this 19-20 September, we reviewed all possible early stage biotech companies in India, including spinoff from India’s most reputable academic institutions and incubation centers. One of the shortlisted companies is InvivoD Solutions, a spin off …

Rohan and colleague at C-CAMP

Gene therapy in India: Meet Viravecs, an early stage biotech

Emily Event News Leave a Comment

Immuno-oncology in preventive healthcare may be a popular trend right now but it is not just big pharma’s game. We observed several interesting start ups in Asia working on finding the solution to cancer, including Viravecs from India tackling the problem from the genetics angle. We spoke with Rohan Kamat, Co-founder of Viravecs who is confirmed to speak at the …

From left, Balasubramaniam (Founder & President), Anand Anandkumar (Founder & CEO), Santanu Datta (CSO)

Meet Bugworks, India biotech working on innovative AMR products

Emily Event News 1 Comment

Antimicrobial resistance (AMR) is a real problem across the global healthcare system. While AMR is observed in infectious agents across different diseases, it now seems to also be being observed in agents causing common yet serious diseases, such as bloodstream infection (sepsis), diarrhoea, pneumonia, gonorrhoea and urinary track infections. Before superbugs become resistant to all of the “last resort” antibiotics, innovative biotech …

5 Questions with Sooraj Ratnakumar

10 minutes with Swagene, an India biotech start up on precision & personalised medicine

Emily Event News Leave a Comment

Following the success of the Biotech Innovation Track at BioPharma Asia 2017 (now rebranded to Phar-East), we are delighted to introduce the same pitching format to the 15th BioPharma India 2017 in Mumbai this 19-20 September, to allow early stage, innovative Indian biotech companies to introduce their company profile and upcoming pipelines to interested investors and potential partners. One of …

C7n_w8QW4AAOfl_

Did You Know? The Straight Facts about the Metabolic Disease Epidemic in Asia

mildred Uncategorised Leave a Comment

Metabolic diseases are one of many healthcare threats faced by the region, and Johnson & Johnson Innovation is committed to working with local governments, industry experts and innovators to develop solutions for patients across the region. Singapore is one of the major innovation hotspots where Johnson & Johnson Innovation is heavily investing efforts to strengthen its entrepreneurial ecosystem, beginning with …

Header

Johnson & Johnson Innovation Strengthens Innovation Hubs in Asia Pacific through Singapore QuickFire Challenge – Metabolic Disease Innovation

mildred Uncategorised Leave a Comment

Asia Pacific is a region changing at a sometimes dizzying pace. Already comprising 60% of the world’s population, it is growing by some 14 million people per year.  Urbanisation is happening at a pace the world has never seen before,  allowing the equally unprecedented growth of the middle class.  Add to the mix some of the world’s most aging populations, …

lab technician pipette liquid into test tubes

Download inVentiv Health’s whitepaper on Understanding the Continuum of Clinical Collaboration: Maximizing Partner Relationships and Unlocking Greater Value

mildred Uncategorised Leave a Comment

As biopharma companies evaluate strategies to advance their products to market, they are increasingly doing so with new options on partnership.  CRO or Vendor partners are invited to solve challenges of capacity, quality, expertise, and infrastructure – but not necessarily all at the same time.  Effective solutions are therefore about taking the BEST approach (Blended Efficient Sustainable Team) that may …

lumosa

Sponsored Blogpost

mildred Uncategorised Leave a Comment

COMPANY INTRODUCTION Lumosa Therapeutics is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases with unmet medical needs. The company is actively engaged in scientific licensing and new drug development under the “RESEARCH and DEVELOPMENT” model. This model is executed by a highly capable and experienced multi-functional team of translational research, CMC, preclinical, …